難治性冠攣縮性狭心症にデノパミンの単独投与が有効であった1例 -その作用の薬理学的機序- by Ishide, Takeshi et al.
Ⅰ．Introduction
 It has been shown that the incidence of vasospastic 
angina pectoris is more frequent in Japanese people than 
in Caucasians, and calcium channel blockers and/or 
nitrates were effective in these patients［1］. Conversely, 
it has been claimed that about 20% of cases are not 
treated effectively with combined administration of 
calcium channel blocker and nitrate［2］.
 In refractory cases, it has been shown that nicorandil, 
sympathetic alpha-1 receptor blockade, steroids, vitamine 
E, magnesium, and bypass surgery were sometimes 
effective. A adrenergic beta receptor （βAR） stimulator-
induced vasodilative response in the coronary arteries has 
been reported［3,4］. Other reports showed that combined 
administration of denopamine, a selective adrenergic 
beta-1 receptor （β1AR） stimulant, was effective in 
cases of refractory vasospastic angina pectoris. However, 
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SUMMARY
A 71-year old man suffered from chest pain on effort. He frequently experienced chest pain in the 
early morning while sleeping. During Holter monitor recording, he suffered from chest pain that ceased 
with sublingual administration of nitroglycerin. The recording showed horizontal type depression of 
the ST segment over 0.2 mV of channel CM5 during chest pain. Therefore, the patient was diagnosed 
with vasospastic angina pectoris.
Administration of isosorbide dinitrate and extended-released nifedipine per os was started, and 
for a while,chest pain ceased. However, after about 1 month, chest pains reappeared during sleep and 
bathing. Isosorbide dinitrate- tape was added, but it was not effective in treating the chest pain. The β1 
selective adrenergic receptor stimulant, denopamine, was then administered to prevent angina attacks. 
In the following month, there was no chest pain. The medicines were discontinud 1 at a time in the 
order isosorbide dinitrate-tape, nifedipine, and isosorbide dinitrate, at intervals of 1 month.
Although denopamine alone remained as a treatment, there were no angina attacks, and 
abnormal changes in the ST segment were not observed on Holter monitoring after 3 months of 
denopamine only. Denopamine alone was effective in the case of refractory vasospastic angina pectoris.
　Key words:  refractory vasospastic angina pectoris, adrenergic beta-1 receptor vasodilation, denoapmine
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there have been few reports that the administration of 
denopamine alone abolishes refractory angina attacks［5］.
 Here, I report on a refractory case whose symptoms 
were relieved by the administration of denopamine 
alone, and on the pharmacological role of β1AR on 
coronary vasodilative action. Additionally, the problems 
of the guidelines for vasospastic angina pectoris edited 
by the Japanese Circulation Association are discussed. 
Ⅱ．Case report
 A 71-year old man with no striking medical history, 
and who had given up smoking 50 years earlier, 
presented with episodes of angina. November 2010, 
he experienced left-sided precordial pain while cycling 
uphill. Soon after taking rest, the pain disappeared. 
Some days later, he woke with precordial pain at about 
4 AM, that disappeared after about 15 min. He then 
suffered from frequent angina episodes during sleep at 
about 4 to 5 AM prior to visiting the outpatient clinic.
 On vising the clinic, his physical examination and 
laboratory tests were normal. Because he was suspected 
of having vasospastic angina pectoris, he was given 
sublingual nitroglycerin tablets to treat the angina 
attacks and put on a Holter monitor （Digital Walk 
FM-150, Fukuda Denshi, Chiba City, Japan）. During 
the monitoring, he experienced an angina attack, and 
he promptly took a nitroglycerin tablet sublingually 
with subsequent disappearance of precordial pain. The 
recording showed horizontal type depression of ST 
segments over 0.2 mV in channel CM5 during the attack 
of pain, and the ST segments returned to the isoelectrical 
level in accordance with the cessation of pain after 
taking nitroglycerin （Fig. 1）［6］. No another abnormal 
ST segment deviation was shown on the recording 
except during the angina attack. Coronary angiography 
was not performed because the patient’s spause had 
regular hemodialysis, and he needed to take care of her.
 Immediately after Holter monitor recording, the 
patient was treated with extended-released nifedipine, 
20 mg/day and isosorbide dinitrate （ISDN）, 40 mg/
day. There were no attacks during therapeutic trials with 
these agents. However, the attacks reccured 1 month 
later while asleep in the early morning and while taking 
a bath in spite of the administration of these agents. 
Additional treatment with ISDN- tape, 40 mg/day, was 
not effective in treating these attacks, but administration 
of sublingual nitrogleycerin stopped the chest pain. An 
additional drug, denopamine, 20mg/day, a selective 
adrenergic beta-1 receptor （β1AR） agonist, prevented 
these angina attacks.
 After confirmation that there had not been any 
angina attacks the previous month, I initiated a trial of 
withdrawal of the other medicines one by one to verify 
the effectiveness of the administration of denopamine 
alone, with the patient’s consent. The patient actively 
Fig. 1　Continuous electrocardiography in a patient with an anginal attack.
　Elctrocardiography is presented by means of superimposed electrocardiogram: 
20 superimposed blocked waves per 5 min, comprising superimposed averaged 
electrocardiographic waves per 15 s block. Data were analyzed using SCM-6000 （Fukuda 
Denshi, Chiba City, Japan）. A. Before angina attack （12 : 15-12 : 20 hours）. B. Initiation 
of ST segments depression （12 : 20-12 : 25 hours）. C. Experiencing angina attack and 
taking a nitrate sublingually （12 : 25-12 : 30 hours）. D. Chest pain ceasing with ST 
segments returned to baseline （12 : 30-12 : 35 hours）.
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consented to this because some medicines would be 
stopped. First, the ISDN-tape was stopped while ISDN, 
nifedipine, and denopamine were continued orally 
on the same doses. The patient was advised that if an 
angina attack occurred, he should take a nitroglycerin 
tablet sublingually immediately and restart the previous 
treatment, namely the ISDN- tape.
 Because there was no angina attack in the next 
month, nifedipine, and then ISDN in turn, were 
withdrawn at monthly intervals after confirmation that 
there had been no chest pain. After taking denopamine 
alone, the patient experienced light chest oppressiveness 
on getting up in the morning for 4 days continuously. 
These symptoms disappeared within 5 minutes after 
taking a nitroglycerin tablet sublingually. After that, 
the patient did not experience these symptoms. After 3 
months of taking denopamine alone, the Holter monitor 
was put on. During monitoring, the patient did not have 
any symptoms and no abnormal ST segment deviation 
was recorded （Fig. 2）. Over a 24-month period, no 
angina attack was observed. Thus, the administration of 
denopamine was fully effective in this case of refractory 
vasospastic angina pectoris.
Ⅲ．Discussion
 Although in this case coronary angiography and a 
drug-induced test for vasospasms were not performed, 
in accordance with the guidelines of the Japanese 
Circulation Association［7］, the diagnosis of refractory 
vasospastic angina pectoris was made for these reasons; 
（1） angina attacks occurred at rest, mainly while asleep; 
（2） ST segment deviation with chest pain was observed 
during Holter monitor recording; （3） administration of 
combined nitrate and a calcium channel blockade did 
not prevent the angina attacks.
 Addition of denopamine to nitrate and the calcium 
channel blocker prevented the angina attacks. After the 
cessation of angina attacks, administration of nitrate 
and the calcium channel blocker were stopped in turn. 
Although finally denopamine alone was given, the 
angina attack did not reccur and the Holter monitor 
recording did not show abnormal ST segment changes. 
It was therefore concluded that the administration 
of denopamine alone was effective in this refractory 
vasospastic angina case. This has seldom been reported 
before［5］.
 It is widely accepted that stimulation of adrenergic 
β1AR and/or β2AR receptors causes dilatation of 
both large and small coronary arteries［8,9］. Although 
Parent et al. showed in dogs that resistant coronary 
arterial dilatation via βAR was caused by nitrogen 
oxide generated in the endothelium［10］, Ghaleh et 
al. concluded that large coronary arterial dilatation by 
denopamine 20mg
ISDN-tape 40mg
ISDN 40mg
0 6 12 Mo
nifedipine 20mg
Fig. 2　Administration of medicines.
　At first, ISDN, 40 mg/day, and extended-released nifrdipine, 20 mg/day, were administered. Thereafter, 
denopamine, 20 mg/day, was added. After confirming that there were no further anginal attacks, ISDN-tape, 
nifedipine, and ISDN were discontinued in turn. Mo, month: ISDN, isosorbide dinitrate. 
32 Takeshi Ishide
stimulation of βAR was a direct reaction mainly caused 
by β1AR, and was neither dependent on coronary 
blood flow nor on the endothelium of vessels in an in 
vivo experiment［11］. In their first report of vasospastic 
angina pectoris, Prinzmetal et al. descrived a case 
who was responsive to the administration of nylidrin 
hydrochloride, a sympathetic vasodilator of peripheral 
arteries［12］.
 Amenta et al. presented data on βAR values 
and the ratio of β1AR and β2AR in human large 
coronary arteries, using radioreceptor binding and 
autoradiographic techniques. Analysis of isoforms 
indicated that the binding capacity in the right coronary 
artery was greater than that in the left coronary artery 
and the anterior interventricular branch; in addition, 
the ratio of β1AR to β2AR was greater in the right 
coronary artery than in the left coronary artery and the 
interventicular branch. The result of autoradiographic 
analysis revealed a predominance of β1AR in the 
medial layer （namely smooth muscle layer） and that 
β2AR was localized primarily in the adventitia, the 
adventitia-media border, and the intimal layer［13］. 
It is thought that the action of the β1AR stimulant is 
different in the region of large coronary arteries.
 Focal spasm has been shown to be most common in 
the right coronary artery［14］. Fifteen cases that included 
data on 18 focal arteries were given denopamine［5,15-
22］. Ten of these focal arteries were the right coronary 
arteries and 8 were the left. Three of 15 cases showed 
both left and right coronary artery spasms. Seven cases 
with sole right coronary artery spasms, 2 sole left, and 
all 3 cases of both right and left were treated effectively 
with denopamine. Ten of the focal arteries were right 
coronary arteries and 5 were left. Thus, denopamine was 
effective in all 10 right coronary arteries. Although there 
are only a few arteries descriving lack of the treatment 
effect of denopamine, these reports were 3 patients all 
with sole left coronary artery spasms［16］. It seemes that 
the right coronary artery cases were more responsive 
to denopamine than the left coronary cases. This might 
be because β1AR was more concentrated in the right 
coronary artery than in the left.
 Shimizu et al. described 2 cases that were not 
responsive to denopamine but did respond to venous 
injection of norepinephrine for the treatment of 
left coronary artery vasospasm［16］. Althogh it is 
known that norepinephrine causes contraction of the 
coronary arteries via the adrenergic alpha-1 receptor, 
Miyashiro and Feigl showed that norepinephrine 
had a direct dilative action on the coronary artery via 
β1AR and β2AR［23］. Further, Sun et al. reported 
that norepinephrine directly dilated human coronary 
arterioles and small arteries isolated from the left 
ventricle via β2AR in an in vivo experiment［24］. In 
patients in whom administration of denopamine is not 
fully effective, consideration should be given to the 
combined administration of denopamine and β2AR 
selective stimulants, reflecting the present-case report 
and the fact that there is a greater concentration of 
β2AR in the left coronary arteries than in the right 
coronary arteries.
 It has been reported that a transplanted heart 
developed vasospastic angina pectoris and a surgical 
denervated heart had vasospasms［25,26］. In these 
studies, the authors reffered to the possibility of other 
factors besides the autonomic nervous system as the 
cause. Almost all medicines to induce diagnostic 
vasospasms and treat angina in patients do not work 
directly on the autonomic nervous system but work on 
vascular receptors. The abnormal function of vascular 
receptors might also be considered as the cause of 
vasospasms.
 The guidelines of the Japanese Circulation 
Association for the treatment of vasospastic angina 
pectoris do not recommend treatment with β1AR 
stimulants［7］. Because the acetylcholine test to induce 
vasospasm is recommended, it seems preferable to 
actively treat with denopamine. 
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